glp 1 drugs for prediabetes GLP-1 Prevention: Using Like Zepbound for Pre-Diabetes or Metabolic Risk -What Does Research Say? Starting a GLP-1? Doctors Reveal

About a third of them had T2D

The European Cardiovascular Health Plan Roadmap from the European Alliance was published earlier in 2025 and calls for comprehensive approaches to incorporate the recognition of obesity as a trigger for cardiovascular disease

Three decades later, we are still teasing apart the details of this crucial physiological mechanism, now responsible for some of the most popular drugs in the world

Incretins Introduction Type 2 diabetes may result from a variety of conditions including -cell dysfunction, where insulin is not produced, and/or due to insulin resistance, in both cases leading to hyperglycemia, and complications in both small and large blood vessels (Silberstein, 2013)

10.1111/obr.12465 [DOI] [PubMed] 2.Leitner DR et al (2017) Obesity and type 2 diabetes: two diseases with a need for combined treatment strategiesEASO Can lead the way

The BMI thresholds remain identical to the injectable version